Predictors of objective response to first-line immuno-oncology combination therapies in metastatic renal cell carcinoma: Results from the international metastatic renal cell database consortium (IMDC).

被引：0
|
作者：
Navani, Vishal
Ernst, Matthew Scott
Wells, Connor
Yuasa, Takeshi
Takemura, Kosuke
Donskov, Frede
Basappa, Naveen S.
Schmidt, Andrew Lachlan
Pal, Sumanta K.
Meza, Luis A.
Wood, Lori
Ernst, D. Scott
Szabados, Bernadett
McKay, Rana R.
Weickhardt, Andrew James
Suarez, Cristina
Kapoor, Anil
Lee, Jae-Lyun
Choueiri, Toni K.
Heng, Daniel Yick Chin
机构：
[1] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[2] Canc Agcy, Vancouver, BC, Canada
[3] Canc Inst Hosp Japanese Fdn Canc Res, Tokyo, Japan
[4] Tokyo Metropolitan Komagome Hosp, Tokyo, Japan
[5] Aarhus Univ Hosp, Aarhus, Denmark
[6] Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada
[7] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA USA
[8] City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut, Duarte, CA USA
[9] City Hope Comprehens Canc Ctr, Duarte, CA USA
[10] Dalhousie Univ, Queen Elizabeth Hlth Sci Ctr 2, Halifax, NS, Canada
[11] London Reg Canc Program, Div Med Oncol, Dept Oncol, London Hlth Sci Ctr, London, ON, Canada
[12] Univ Western Ontario, London, ON, Canada
[13] Barts Canc Inst, London, England
[14] Univ Calif San Diego, La Jolla, CA USA
[15] Austin Hlth, Olivia Newton John Canc Wellness & Res Ctr, Melbourne, Vic, Australia
[16] Hosp Univ Vall Hebron, Vall Hebron Inst Oncol VHIO, Vall Hebron Barcelona Hosp Campus, Barcelona, Spain
[17] McMaster Univ, Juravinski Canc Ctr, Hamilton, ON, Canada
[18] Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea
[19] Univ Ulsan, Coll Med, Seoul, South Korea
[20] Brigham & Womens Hosp, Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA USA
[21] Harvard Med Sch, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 06期
关键词：
D O I：
10.1200/JCO.2022.40.6_suppl.310
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
310
引用
收藏
页数：4
相关论文
共 50 条
  • [21] First line sunitinib versus pazopanib in metastatic renal cell carcinoma: results from the international metastatic renal cell carcinoma database consortium
    Morales, Jose Manuel Ruiz
    Wells, J. Connor
    Donskov, Frede
    Bjarnason, Georg A.
    Lee, Jae Lyun
    Knox, Jennifer J.
    Beuselinck, Benoit
    Vasihampayan, Ulka
    Brugarolas, James
    Broom, Reuben
    Koutsoukos, Konstantinos
    Yuasa, Takeshi
    Srinivas, Sandy
    Ernst, D. Scott
    Pezaro, Carmel
    Wood, Lori A.
    Kollmannsberger, Christian
    Rini, Brian I.
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    [J]. BJU INTERNATIONAL, 2015, 116 : 20 - 20
  • [22] Real world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Stukalin, Igor
    Wells, J. Connor
    Graham, Jeffrey
    Yuasa, Takeshi
    Beuselinck, Benoit
    Kollmannsberger, Christian K.
    Ernst, D. Scott
    Agarwal, Neeraj
    Le, Tri
    Donskov, Frede
    Hansen, Aaron Richard
    Bjarnason, Georg A.
    Srinivas, Sandy
    Wood, Lori
    Alva, Ajjai Shivaram
    Kanesvaran, Ravindran
    Fu, Simon Yuen Fai
    Davis, Ian D.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [23] First-line mTOR inhibition in metastatic renal cell carcinoma (mRCC): An updated analysis from the International mRCC Database Consortium (IMDC).
    Harshman, Lauren Christine
    Kroeger, Nils
    Rha, Sun Young
    Donskov, Frede
    Wood, Lori
    Tantravahi, Srinivas Kiran
    Vaishampayan, Ulka N.
    Rini, Brian I.
    Knox, Jennifer J.
    North, Scott A.
    MacKenzie, Mary J.
    Yuasa, Takeshi
    Srinivas, Sandy
    Pal, Sumanta Kumar
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] Real world experience of immuno-oncology agents in metastatic renal cell carcinoma: Results from the IMDC.
    Yip, Steven
    Wells, Connor
    Moreira, Raphael Brandao
    Wong, Alex
    Srinivas, Sandy
    Beuselinck, Benoit
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [25] Third line therapy in metastatic renal cell carcinoma (mRCC): results from the international mRCC database consortium (IMDC)
    Stukalina, Igor
    Wellsa, J. Connor
    Donskovb, Frede
    Rinic, Brian I.
    Leed, Jae-Lyun
    Bjarnasone, Georg A.
    Beuselinckf, Benoit
    Smoragiewicz, Martin
    Alvah, Ajjai Shivaram
    Srinivasi, Sandy
    Woodi, Lori
    Saleemk, Sadia
    Pal, Sumanta Kumar
    Yuasam, Takeshi
    Broomn, Reuben James
    Kanesvaran, Ravindran
    Bamiasp, Aristotelis
    Knoxq, Jennifer J.
    Henga, Daniel Y. C.
    Choueirir, Toni K.
    [J]. BJU INTERNATIONAL, 2015, 116 : 21 - 21
  • [26] Prognostic significance of absolute lymphocyte count in patients with metastatic renal cell carcinoma receiving first-line combination immunotherapies: results from the International Metastatic Renal Cell Carcinoma Database Consortium
    Takemura, K.
    Yuasa, T.
    Lemelin, A.
    Ferrier, E.
    Wells, J. C.
    Saad, E.
    Saliby, R. M.
    Basappa, N. S.
    Wood, L. A.
    Jude, E.
    Pal, S. K.
    Donskov, F.
    Beuselinck, B.
    Szabados, B.
    Powles, T.
    McKay, R. R.
    Gebrael, G.
    Agarwal, N.
    Choueiri, T. K.
    Heng, D. Y. C.
    [J]. ESMO OPEN, 2024, 9 (07)
  • [27] Checkpoint inhibitors in metastatic renal cell carcinoma patients including elderly subgroups: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Yip, Steven
    Wells, Connor
    Moreira, Raphael Brandao
    Wong, Alex
    Srinivas, Sandy
    Beuselinck, Benoit
    Porta, Camillo
    Sim, Hao-Wen
    Ernst, D. Scott
    Rini, Brian I.
    Yuasa, Takeshi
    Basappa, Naveen S.
    Kanesvaran, Ravindran
    Wood, Lori
    Canil, Christina M.
    Kapoor, Anil
    Fu, Simon Yuen Fai
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] Outcomes of patients with brain metastases from renal cell carcinoma treated with firstline therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Takemura, Kosuke
    Lemelin, Audreylie
    Ernst, Matthew Scott
    Wells, Connor
    Basappa, Naveen S.
    Szabados, Bernadett
    Powles, Thomas
    Davis, Ian D.
    Wood, Lori
    Kapoor, Anil
    Mckay, Rana R.
    Lee, Jae-Lyun
    Meza, Luis A.
    Pal, Sumanta Monty
    Donskov, Frede
    Yuasa, Takeshi
    Gebrael, Benoit Beuselinck Georges
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [29] Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma (vol 84, pg 109, 2023)
    Ernst, Matthew S.
    Navani, Vishal
    Wells, J. Connor
    Donskov, Frede
    Basappa, Naveen
    Labaki, Chris
    Pal, Sumanta K.
    Meza, Luis
    Wood, Lori A.
    Ernst, D. Scott
    Szabados, Bernadett
    McKay, Rana R.
    Parnis, Francis
    Suarez, Cristina
    Yuasa, Takeshi
    Lalani, Aly-Khan
    Alva, Ajjai
    Bjarnason, Georg A.
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    [J]. EUROPEAN UROLOGY, 2023, 83 (06) : E166 - E167
  • [30] Characterization of patients with metastatic renal cell carcinoma treated with or without cytoreductive nephrectomy in the era of combination immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)
    Takemura, K.
    Ernst, M.
    Navani, V
    Wells, J. C.
    Bakouny, Z.
    Donskov, F.
    Basappa, N. S.
    Wood, L. A.
    Meza, L.
    Pal, S. K.
    Szabados, B.
    Powles, T.
    Beuselinck, B.
    Mckay, R. R.
    Lee, J-L
    Ernst, D. S.
    Kapoor, A.
    Yuasa, T.
    Choueiri, T. K.
    Heng, D. Y. C.
    [J]. EUROPEAN UROLOGY, 2023, 83 : S473 - S474
12345